K2M Receives FDA Clearance for BACSĀ® Patient-Specific Module

Go back to K2M Receives FDA Clearance for BACSĀ® Patient-Specific Module
K2M GROUP HOLDINGS (NASDAQ: KTWO) Delayed: 9.93 -0.12 (1.19%)
Previous Close $10.05    52 Week High $21.67 
Open $9.98    52 Week Low $10.10 
Day High $9.98    P/E N/A 
Day Low $9.93    EPS $0.00 
Volume 1,502